Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-14.6%
5Y CAGR-4.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-14.6%/yr
vs +14.9%/yr prior
5Y CAGR
-4.1%/yr
Recent deceleration
Acceleration
-29.4pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$209.31M-23.4%
2024$273.22M-16.7%
2023$327.83M-2.3%
2022$335.69M+14.1%
2021$294.28M+14.0%
2020$258.24M+27.8%
2019$202.01M+4.8%
2018$192.84M+9642000.0%
2017$2000.00-